Session four: Genetics to clinical trials and therapies

SESSION CHAIR: To be announced

8:00 a.m.
Hampton Leonard, M.S.— National Institutes of Health
Implementation of clinical trials using genomic data: advantages and limitations

8:30 a.m.
Joseph Lewcock, Ph.D.—Denali Therapeutics
Precision medicine in PD: a drug developer’s perspective

9:00 a.m.
Michelle Penny, Ph.D.—Biogen
Anti-alpha-synuclein ASO

9:30 a.m.
Brian Fiske, Ph.D. — The Michael J. Fox Foundation for Parkinson’s Research
Enabling genetic discovery and translation in the Parkinson’s therapeutic pipeline: A strategic funder’s perspective

9:45 a.m.

Location: Tomatis Auditorium Date: August 22, 2019 Time: 8:00 am - 10:00 am Hampton Leonard, M.S. Joseph W. Lewcock, Ph.D. Michelle Penny, Ph.D.